HRP20050390A2 - Substituted benzoxazinones and uses thereof - Google Patents
Substituted benzoxazinones and uses thereofInfo
- Publication number
- HRP20050390A2 HRP20050390A2 HR20050390A HRP20050390A HRP20050390A2 HR P20050390 A2 HRP20050390 A2 HR P20050390A2 HR 20050390 A HR20050390 A HR 20050390A HR P20050390 A HRP20050390 A HR P20050390A HR P20050390 A2 HRP20050390 A2 HR P20050390A2
- Authority
- HR
- Croatia
- Prior art keywords
- substituted benzoxazinones
- formula
- benzoxazinones
- substituted
- methods
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D265/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms
- C07D265/28—1,4-Oxazines; Hydrogenated 1,4-oxazines
- C07D265/34—1,4-Oxazines; Hydrogenated 1,4-oxazines condensed with carbocyclic rings
- C07D265/36—1,4-Oxazines; Hydrogenated 1,4-oxazines condensed with carbocyclic rings condensed with one six-membered ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D291/00—Heterocyclic compounds containing rings having nitrogen, oxygen and sulfur atoms as the only ring hetero atoms
- C07D291/08—Heterocyclic compounds containing rings having nitrogen, oxygen and sulfur atoms as the only ring hetero atoms condensed with carbocyclic rings or ring systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D419/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen, oxygen, and sulfur atoms as the only ring hetero atoms
- C07D419/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen, oxygen, and sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D419/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen, oxygen, and sulfur atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Veterinary Medicine (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Biomedical Technology (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Psychiatry (AREA)
- Pain & Pain Management (AREA)
- Hospice & Palliative Care (AREA)
- Child & Adolescent Psychology (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Psychology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Plural Heterocyclic Compounds (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US42494602P | 2002-11-08 | 2002-11-08 | |
| PCT/EP2003/012278 WO2004041792A1 (en) | 2002-11-08 | 2003-11-04 | Substituted benzoxazinones and uses thereof |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| HRP20050390A2 true HRP20050390A2 (en) | 2006-12-31 |
Family
ID=32312902
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HR20050390A HRP20050390A2 (en) | 2002-11-08 | 2005-05-02 | Substituted benzoxazinones and uses thereof |
Country Status (28)
| Country | Link |
|---|---|
| US (1) | US7141562B2 (zh) |
| EP (1) | EP1562918B1 (zh) |
| JP (1) | JP4401297B2 (zh) |
| KR (1) | KR100683361B1 (zh) |
| CN (1) | CN100390157C (zh) |
| AR (1) | AR042002A1 (zh) |
| AT (1) | ATE384054T1 (zh) |
| AU (1) | AU2003293653B2 (zh) |
| BR (1) | BR0315302A (zh) |
| CA (1) | CA2505334A1 (zh) |
| DE (1) | DE60318733T2 (zh) |
| DK (1) | DK1562918T3 (zh) |
| ES (1) | ES2298609T3 (zh) |
| GT (1) | GT200300241A (zh) |
| HR (1) | HRP20050390A2 (zh) |
| IL (1) | IL168343A (zh) |
| MX (1) | MXPA05004758A (zh) |
| MY (1) | MY136824A (zh) |
| NO (1) | NO20052074L (zh) |
| NZ (1) | NZ539508A (zh) |
| PA (1) | PA8587501A1 (zh) |
| PE (1) | PE20040828A1 (zh) |
| PL (1) | PL377770A1 (zh) |
| PT (1) | PT1562918E (zh) |
| RU (1) | RU2328490C2 (zh) |
| TW (1) | TWI285639B (zh) |
| WO (1) | WO2004041792A1 (zh) |
| ZA (1) | ZA200503248B (zh) |
Families Citing this family (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2453837C (en) * | 2001-07-20 | 2011-10-04 | Psychogenics, Inc. | Treatment for attention-deficit hyperactivity disorder using eltoprazine and related compounds |
| PL209872B1 (pl) | 2002-03-27 | 2011-10-31 | Glaxo Group Ltd | Pochodna chinolinowa, sposób jej wytwarzania i jej zastosowanie oraz zawierająca ją farmaceutyczna kompozycja |
| RS20060035A (en) | 2003-07-22 | 2008-08-07 | Arena Pharmaceuticals Inc., | Diaryl and arylheteroaryl urea derivatives as modulators of the 5-ht2a serotonin receptor useful for the prophylaxis and treatment of disorders related thereto |
| ES2291984T3 (es) * | 2003-12-09 | 2008-03-01 | F. Hoffmann-La Roche Ag | Derivados de benzoxazina y su empleo. |
| ES2359725T3 (es) * | 2004-09-30 | 2011-05-26 | F. Hoffmann-La Roche Ag | Composiciones y métodos para el tratamiento de trastornos cognitivos. |
| US7713954B2 (en) * | 2004-09-30 | 2010-05-11 | Roche Palo Alto Llc | Compositions and methods for treating cognitive disorders |
| WO2007006677A1 (en) * | 2005-07-13 | 2007-01-18 | F. Hoffmann-La Roche Ag | Benzimidazole derivatives as 5-ht6,5-ht24 |
| JP2009514795A (ja) * | 2005-09-15 | 2009-04-09 | コリア リサーチ インスティテュート オブ ケミカル テクノロジー | Ｎ−置換−１ｈ−キノリン−２，４−ジオン化合物、その製造方法及びそれを含む薬学的組成物 |
| PT2040755E (pt) * | 2006-06-23 | 2011-07-08 | Esteve Labor Dr | Combinação de um inibidor de colinesterase e um composto com afinidade para o receptor 5-ht6 |
| WO2009074607A1 (en) | 2007-12-12 | 2009-06-18 | Glaxo Group Limited | Combinations comprising 3-phenylsulfonyl-8-piperazinyl-1yl-quinoline |
| WO2009123714A2 (en) | 2008-04-02 | 2009-10-08 | Arena Pharmaceuticals, Inc. | Processes for the preparation of pyrazole derivatives useful as modulators of the 5-ht2a serotonin receptor |
| US9126946B2 (en) | 2008-10-28 | 2015-09-08 | Arena Pharmaceuticals, Inc. | Processes useful for the preparation of 1-[3-(4-bromo-2-methyl-2H-pyrazol-3-yl)-4-methoxy-phenyl]-3-(2,4-difluoro-phenyl)urea and crystalline forms related thereto |
| ITMI20131782A1 (it) * | 2013-10-25 | 2015-04-26 | Dipharma Francis Srl | Procedimento per la preparazione di un agonista della trombopoietina |
| CN109562085A (zh) | 2015-06-12 | 2019-04-02 | 阿速万科学有限责任公司 | 用于预防和治疗rem睡眠行为障碍的二芳基和芳基杂芳基脲衍生物 |
| AU2016291673A1 (en) | 2015-07-15 | 2018-01-25 | Axovant Sciences Gmbh | Diaryl and arylheteroaryl urea derivatives for the prophylaxis and treatment of hallucinations associated with a neurodegenerative disease |
| RU2624978C2 (ru) * | 2015-07-27 | 2017-07-11 | Государственное бюджетное образовательное учреждение высшего профессионального образования "Воронежский государственный медицинский университет им. Н.Н. Бурденко" Министерства здравоохранения Российской Федерации | Способ лечения умеренного когнитивного снижения |
| HUE055186T2 (hu) * | 2017-08-07 | 2021-11-29 | Suven Life Sciences Ltd | Fluoro-piperidin vegyületek, mint tiszta 5-HT6 receptor antagonisták |
| CN111559990B (zh) * | 2020-05-29 | 2021-03-09 | 四川大学华西医院 | 一种小分子噁噻嗪类衍生物及其应用 |
| CN112047898A (zh) * | 2020-10-14 | 2020-12-08 | 兰州大学 | 一种苯并[c][1,2]噁嗪骨架类新化合物及其制备方法 |
Family Cites Families (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE3586794T2 (de) | 1984-12-21 | 1993-05-27 | Duphar Int Res | Arzneimittel mit psychotroper wirkung. |
| AU605304B2 (en) * | 1987-06-22 | 1991-01-10 | Nihon Tokushu Nayaku Seizo K.K. | Benzo-fused cyclic compounds |
| FR2667068B1 (fr) * | 1990-09-26 | 1994-09-09 | Adir | Nouvelles amines alkyl heterocycliques, leur procede de preparation et les compositions pharmaceutiques qui les contiennent. |
| US5955470A (en) * | 1991-06-11 | 1999-09-21 | Merrell Pharmaceuticals, Inc. | Derivatives of amide analogs of certain methano bridged quinolizines |
| PL189256B1 (pl) | 1996-03-29 | 2005-07-29 | Duphar Int Res | Związki piperazyny i piperydyny, sposób ich wytwarzania, kompozycja farmaceutyczna zawierająca te związki, zastosowanie tych związków do wytwarzania leków |
| DE69819266T2 (de) | 1997-09-02 | 2004-07-29 | Duphar International Research B.V. | Piperidin- und Piperazin Derivate als 5-HT1-Rezeptor-Agonisten |
| PL201178B1 (pl) * | 1999-08-23 | 2009-03-31 | Solvay Pharm Bv | Nowe pochodne fenylopiperazyny, sposób ich wytwarzania, kompozycja farmaceutyczna oraz zastosowanie |
| EP1255743A1 (en) | 2000-02-01 | 2002-11-13 | Millenium Pharmaceuticals, Inc. | 3,4-DIHYDRO-2H-BENZO[1,4]OXAZINE INHIBITORS OF FACTOR Xa |
| US20020019394A1 (en) | 2000-03-24 | 2002-02-14 | Wenhao Li | Bicyclic sulfonyl amino inhibitors of factor Xa |
| DE10031391A1 (de) | 2000-07-03 | 2002-02-07 | Knoll Ag | Bicyclische Verbindungen und ihre Verwendung zur Prophylaxe und Therapie der zerebralen Ischämie |
| CA2426706A1 (en) * | 2000-10-26 | 2002-05-02 | Smithkline Beecham P.L.C. | Benzoxazinone derivatives, their preparation and use |
| HUP0401235A2 (hu) * | 2001-08-10 | 2004-10-28 | F. Hoffmann-La Roche Ag | 5-HT6 receptor affinitással rendelkező arilszulfonil-származékok, eljárás előállításukra és a vegyületeket tartalmazó gyógyászati készítmények |
| PL211057B1 (pl) * | 2002-05-13 | 2012-04-30 | Hoffmann La Roche | Pochodne benzoksazyny, sposób ich wytwarzania, środek farmaceutyczny i zastosowanie pochodnych benzoksazyny |
-
2003
- 2003-11-04 CN CNB2003801053862A patent/CN100390157C/zh not_active Expired - Fee Related
- 2003-11-04 BR BR0315302-9A patent/BR0315302A/pt not_active Application Discontinuation
- 2003-11-04 AT AT03789002T patent/ATE384054T1/de active
- 2003-11-04 CA CA002505334A patent/CA2505334A1/en not_active Abandoned
- 2003-11-04 PL PL377770A patent/PL377770A1/pl unknown
- 2003-11-04 ES ES03789002T patent/ES2298609T3/es not_active Expired - Lifetime
- 2003-11-04 DK DK03789002T patent/DK1562918T3/da active
- 2003-11-04 KR KR1020057008044A patent/KR100683361B1/ko not_active IP Right Cessation
- 2003-11-04 TW TW092130842A patent/TWI285639B/zh active
- 2003-11-04 AU AU2003293653A patent/AU2003293653B2/en not_active Ceased
- 2003-11-04 MX MXPA05004758A patent/MXPA05004758A/es active IP Right Grant
- 2003-11-04 PT PT03789002T patent/PT1562918E/pt unknown
- 2003-11-04 DE DE60318733T patent/DE60318733T2/de not_active Expired - Lifetime
- 2003-11-04 RU RU2005117965/04A patent/RU2328490C2/ru not_active IP Right Cessation
- 2003-11-04 EP EP03789002A patent/EP1562918B1/en not_active Expired - Lifetime
- 2003-11-04 NZ NZ539508A patent/NZ539508A/en not_active IP Right Cessation
- 2003-11-04 JP JP2004549101A patent/JP4401297B2/ja not_active Expired - Fee Related
- 2003-11-04 WO PCT/EP2003/012278 patent/WO2004041792A1/en active IP Right Grant
- 2003-11-05 PA PA20038587501A patent/PA8587501A1/es unknown
- 2003-11-05 PE PE2003001114A patent/PE20040828A1/es not_active Application Discontinuation
- 2003-11-06 GT GT200300241A patent/GT200300241A/es unknown
- 2003-11-06 US US10/702,302 patent/US7141562B2/en not_active Expired - Fee Related
- 2003-11-07 MY MYPI20034282A patent/MY136824A/en unknown
- 2003-11-07 AR ARP030104100A patent/AR042002A1/es unknown
-
2005
- 2005-04-21 ZA ZA200503248A patent/ZA200503248B/en unknown
- 2005-04-27 NO NO20052074A patent/NO20052074L/no not_active Application Discontinuation
- 2005-05-02 IL IL168343A patent/IL168343A/en not_active IP Right Cessation
- 2005-05-02 HR HR20050390A patent/HRP20050390A2/xx not_active Application Discontinuation
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HRP20050390A2 (en) | Substituted benzoxazinones and uses thereof | |
| HRP20050775A2 (en) | Quinolinone/benzoxazinone derivatives and uses thereof | |
| HRP20050213A2 (en) | 2,4-substituted indoles and their use as 5-ht6 modulators | |
| ATE338461T1 (de) | Pyrazolpyrimidinfungizide | |
| BRPI0508966A (pt) | composto, composição farmacêutica, e, uso de um composto | |
| MY141255A (en) | Phosphodiesterase 4 inhibitors, including n-substituted diarylamine analogs | |
| SE0202133D0 (sv) | Novel compounds | |
| ME00411B (me) | Nova jedinjenja koja imaju inhibitorno dejstvo na transporter glukoze zavistan od natrijuma | |
| EP1674452A4 (en) | NOVEL 4-PHENYLAMINO-BENZALDOXIME DERIVATIVE AND ITS USE AS MEK INHIBITOR | |
| ATE374190T1 (de) | Tetrahydrochinazolinderivate als cfr-antagonisten | |
| NO20025641D0 (no) | Substituerte 1-aminoalkyl-laktamer og deres anvendelse som muscarin-reseptor-antagonister | |
| MY139612A (en) | Benzoxazine derivatives as 5-th6 modulators and uses thereof | |
| HRP20070286T3 (en) | Substituted diketopiperazines and their use as oxytocyn antagonists | |
| BRPI0409105A (pt) | análogos de quinobenzoxazina substituìdos | |
| SE0403171D0 (sv) | New compounds | |
| HK1081194A1 (en) | 6-amino-1h-indazole compounds as phosphodiesterase4 inhibitors, pharmaceutical compositions compris ing the same, and use thereof | |
| MY138466A (en) | Aminoalkoxyndoles as 5-ht6-receptor ligands for the treatment of cns-disorders | |
| UY27980A1 (es) | Indoles 2,7-sustituidos | |
| BRPI0416873A (pt) | derivados de benzoxazina e usos dos mesmos | |
| DE69933885D1 (de) | Triphenylbutenderivate zur behandlung von neurologischen störungen | |
| RS50905B (sr) | Derivati benzopirana supstituisani sa sekundarnim aminima uključujući tetrazol, postupak za njihovo dobijanje i farmaceutske kompozicije koje ih sadrže | |
| DK1628968T3 (da) | 4-imidazolin-2-on-forbindelser | |
| TWI263639B (en) | Novel tetrazole derivative | |
| UY26251A1 (es) | Forma cristalina iii de la n- (4-(5- dimetilaminonaftalen-1- sulfonilamino) fenil) -3 - hidroxi-2, 2- dimetilpropionamida | |
| UY28068A1 (es) | Benzoxazinonas sustituidas y usos de las mismas |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A1OB | Publication of a patent application | ||
| ARAI | Request for the grant of a patent on the basis of the submitted results of a substantive examination of a patent application | ||
| ODRP | Renewal fee for the maintenance of a patent |
Payment date: 20101029 Year of fee payment: 8 |
|
| OBST | Application withdrawn |